Thinking Beyond Science

Aging brings a wave of changes—psychological, physiological, and especially cognitive. Many people experience a decline in thinking skills, which can erode independence and quality of life. But this isn’t uniform; individual differences in “normal” cognitive aging stem from multiple factors. Genetics account for 26% to 54% of the variance, while the rest ties to environmental influences like demographics, social connections, education, psychology, medicine, diet, stress, and physical exercise.

Genes like COMT highlight how DNA shapes cognition. COMT degrades dopamine in the brain’s cortex, a key player in focus and decision-making. The “val” version of the protein works more efficiently than the “met” allele due to stability differences. As a result, val carriers often perform worse on working memory tasks—from childhood into adulthood—compared to met carriers.

Working memory itself is a powerhouse, handling the storage and manipulation of information for complex tasks (as Baddeley described in 1990). Picture it as subsystems for storage, guided by a central executive, fueling everything from problem-solving to learning.

Other genes add layers. DISC1, expressed in emotion-regulating brain areas, influences cell migration and neuron growth; it’s linked to schizophrenia and disrupts limbic function. Schizophrenia, a disorder hitting perception, social skills, and cognition, has strong genetic roots. Replicated studies point to genes like dysbindin, neuregulin 1 (NRG1), DISC1, and G72 (now DAOA, or D-amino acid oxidase activator).

Disorders like dyslexia offer clearer windows into genetics because reading development is well-mapped cognitively. Dyslexia’s precise diagnostic traits—broken into components—serve as “endophenotypes” for genetic and brain imaging research, unlike fuzzier areas like emotion regulation in other psychopathologies.

Pinpointing genes for broader traits like intelligence or late-onset dementias is tougher. Measurements are debated, environments and epigenetics muddy the waters, and many genes interact. Alzheimer’s disease exemplifies this: it starts with episodic memory loss, progressing to executive, visuospatial, language, and motor skill deficits. Pathologically, it’s marked by senile plaques (with beta-amyloid, alpha-antichymotrypsin, apolipoprotein E, and cellular debris) and neurofibrillary tangles in signature patterns.

Down syndrome (DS) nearly always leads to Alzheimer’s pathology by age 50. Most cases (95%) involve full chromosome 21 triplication; 4% are partial, via translocations to chromosomes 14 or 22. DS brains differ early—shorter anterior-posterior length, smaller frontal lobes, cerebellum, and hippocampi, plus fewer neurons in temporal cortex, hippocampus, and brainstem—which may fuel baseline intellectual gaps and later decline.

Glutamate steps in as a hopeful target for boosting cognition. This neurotransmitter system, especially NMDA receptors, drives synaptic plasticity—the foundation of learning and memory. Long-term potentiation via NMDA is key (as studies from Cotman et al. in 1988 showed). Block it with antagonists like ketamine, and memory falters in mice and humans. In schizophrenia, glutamatergic glitches link to cognitive woes, suggesting NMDA-enhancing treatments could sharpen thinking.

These insights—from COMT’s dopamine tweaks to glutamate’s potential—paint a multifactorial picture of cognitive health. While genes set the stage, lifestyle factors offer leverage against aging’s toll.

Source : The Genetics of Cognitive Neuroscience by Terry E. Goldberg (Editor), Daniel R. Weinberger (Editor)

Goodreads : https://www.goodreads.com/book/show/6902204-the-genetics-of-cognitive-neuroscience

Read the Previous Article in the Series :